Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2013, Article ID 501851, 14 pages
http://dx.doi.org/10.1155/2013/501851
Review Article

Assessment and Molecular Actions of Endocrine-Disrupting Chemicals That Interfere with Estrogen Receptor Pathways

Institut de Recherche en Santé Environnement Travail (IRSET), INSERM U1085, TREC Team, SFR Biosit, University of Rennes 1, 35042 Rennes Cedex, France

Received 8 January 2013; Revised 26 March 2013; Accepted 28 March 2013

Academic Editor: Ewa Gregoraszczuk

Copyright © 2013 Gwenneg Kerdivel et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. V. Pelekanou and G. Leclercq, “Recent insights into the effect of natural and environmental estrogens on mammary development and carcinogenesis,” The International Journal of Developmental Biology, vol. 55, pp. 869–878, 2011. View at Google Scholar
  2. R. J. Kavlock, G. P. Daston, C. DeRosa et al., “Research needs for the risk assessment of health and environmental effects of endocrine disrupters: a report of the U.S. EPA-sponsored workshop,” Environmental Health Perspectives, vol. 104, supplement 4, pp. 715–740, 1996. View at Google Scholar · View at Scopus
  3. E. K. Shanle and W. Xu, “Endocrine disrupting chemicals targeting estrogen receptor signaling: identification and mechanisms of action,” Chemical Research in Toxicology, vol. 24, no. 1, pp. 6–19, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. T. Lóránd, E. Vigh, and J. Garai, “Hormonal action of plant derived and anthropogenic non-steroidal estrogenic compounds: phytoestrogens and xenoestrogens,” Current Medicinal Chemistry, vol. 17, no. 30, pp. 3542–3574, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Kortenkamp and R. Altenburger, “Synergisms with mixtures of xenoestrogens: a reevaluation using the method of isoboles,” Science of the Total Environment, vol. 221, no. 1, pp. 59–73, 1998. View at Publisher · View at Google Scholar · View at Scopus
  6. D. W. Singleton and S. A. Khan, “Xenoestrogen exposure and mechanisms of endocrine disruption,” Frontiers in Bioscience, vol. 8, pp. s110–s118, 2003. View at Google Scholar · View at Scopus
  7. J. M. Harrington, G. F. Stein, R. O. Rivera, and A. V. de Morales, “The occupational hazards of formulating oral contraceptives. A survey of plant employees,” Archives of Environmental Health, vol. 33, no. 1, pp. 12–15, 1978. View at Google Scholar · View at Scopus
  8. G. H. Degen and H. M. Bolt, “Endocrine disruptors: update on xenoestrogens,” International Archives of Occupational and Environmental Health, vol. 73, no. 7, pp. 433–441, 2000. View at Publisher · View at Google Scholar · View at Scopus
  9. R. R. Newbold, “Prenatal exposure to diethylstilbestrol (DES),” Fertility and Sterility, vol. 89, no. 2, pp. e55–e56, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. L. Multigner, J. R. Ndong, A. Giusti et al., “Chlordecone exposure and risk of prostate cancer,” Journal of Clinical Oncology, vol. 28, no. 21, pp. 3457–3462, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. Z. H. Liu, Y. Kanjo, and S. Mizutani, “A review of phytoestrogens: their occurrence and fate in the environment,” Water Research, vol. 44, no. 2, pp. 567–577, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. R. M. Evans, “The steroid and thyroid hormone receptor superfamily,” Science, vol. 240, no. 4854, pp. 889–895, 1988. View at Google Scholar · View at Scopus
  13. A. C. W. Pike, “Lessons learnt from structural studies of the oestrogen receptor,” Best Practice and Research, vol. 20, no. 1, pp. 1–14, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Boudot, G. Kerdivel, D. Habauzit et al., “Differential estrogen-regulation of CXCL12 chemokine receptors, CXCR4 and CXCR7, contributes to the growth effect of estrogens in breast cancer cells,” PLoS ONE, vol. 6, no. 6, Article ID e20898, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. L. Cicatiello, C. Scafoglio, L. Altucci et al., “A genomic view of estrogen actions in human breast cancer cells by expression profiling of the hormone-responsive transcriptome,” Journal of Molecular Endocrinology, vol. 32, no. 3, pp. 719–775, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. G. Kerdivel, A. Boudot, and F. Pakdel, “Estrogen represses CXCR7 gene expression by inhibiting the recruitment of NFκB transcription factor at the CXCR7 promoter in breast cancer cells,” Biochemical and Biophysical Research Communications, vol. 431, pp. 729–733, 2013. View at Google Scholar
  17. S. Nilsson, S. Mäkelä, E. Treuter et al., “Mechanisms of estrogen action,” Physiological Reviews, vol. 81, no. 4, pp. 1535–1565, 2001. View at Google Scholar · View at Scopus
  18. P. La Rosa, V. Pesiri, G. Leclercq, M. Marino, and F. Acconcia, “Palmitoylation regulates 17β-estradiol-induced estrogen receptor-α degradation and transcriptional activity,” Molecular Endocrinology, vol. 26, pp. 762–774, 2012. View at Google Scholar
  19. A. Pedram, M. Razandi, M. Aitkenhead, C. C. W. Hughes, and E. R. Levin, “Integration of the non-genomic and genomic actions of estrogen: membrane-initiated signaling by steroid to transcription and cell biology,” The Journal of Biological Chemistry, vol. 277, no. 52, pp. 50768–50775, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Safe and K. Kim, “Non-classical genomic estrogen receptor (ER)/specificity protein and ER/activating protein-1 signaling pathways,” Journal of Molecular Endocrinology, vol. 41, no. 5-6, pp. 263–275, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. L. Celik, J. D. D. Lund, and B. Schiøtt, “Exploring interactions of endocrine-disrupting compounds with different conformations of the human estrogen receptor α ligand binding domain: a molecular docking study,” Chemical Research in Toxicology, vol. 21, no. 11, pp. 2195–2206, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. G. Kerdivel, R. Le Guevel, D. Habauzit, F. Brion, S. Ait-Aissa, and F. Pakdel, “Estrogenic potency of benzophenone UV filters in breast cancer cells: proliferative and transcriptional activity substantiated by docking analysis,” PLoS ONE, vol. 8, no. 4, Article ID e60567, 2013. View at Google Scholar
  23. J. R. Gosden, P. G. Middleton, and D. Rout, “Localization of the human oestrogen receptor gene to chromosome 6q24–q27 by in situ hybridization,” Cytogenetics and Cell Genetics, vol. 43, no. 3-4, pp. 218–220, 1986. View at Google Scholar · View at Scopus
  24. E. Enmark, M. Pelto-Huikko, K. Grandien et al., “Human estrogen receptor β-gene structure, chromosomal localization, and expression pattern,” Journal of Clinical Endocrinology and Metabolism, vol. 82, no. 12, pp. 4258–4265, 1997. View at Google Scholar · View at Scopus
  25. G. Flouriot, C. Griffin, M. Kenealy, V. Sonntag-Buck, and F. Gannon, “Differentially expressed messenger RNA isoforms of the human estrogen receptor-α gene are generated by alternative splicing and promoter usage,” Molecular Endocrinology, vol. 12, no. 12, pp. 1939–1954, 1998. View at Google Scholar · View at Scopus
  26. Y. Okuda, S. Hirata, N. Watanabe, T. Shoda, J. Kato, and K. Hoshi, “Novel splicing events of untranslated first exons in human estrogen receptor alpha (ERα) gene,” Endocrine Journal, vol. 50, no. 1, pp. 97–104, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. G. Flouriot, H. Brand, S. Denger et al., “Identification of a new isoform of the human estrogen receptor-alpha (hER-α) that is encoded by distinct transcripts and that is abide to repress hER-α activation function 1,” The EMBO Journal, vol. 19, no. 17, pp. 4688–4700, 2000. View at Google Scholar · View at Scopus
  28. G. Penot, C. Le Péron, Y. Mérot et al., “The human estrogen receptor-alpha isoform hERalpha46 antagonizes the proliferative influence of hERalpha66 in MCF7 breast cancer cells,” Endocrinology, vol. 146, pp. 5474–5484, 2005. View at Google Scholar
  29. Y. W. Zhao, X. Zhang, P. Shen, B. W. Loggie, Y. Chang, and T. F. Deuel, “Identification, cloning, and expression of human estrogen receptor-α36, a novel variant of human estrogen receptor-α66,” Biochemical and Biophysical Research Communications, vol. 336, no. 4, pp. 1023–1027, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. H. Shi, H. Shigeta, N. Yang, K. Fu, G. O'Brian, and C. T. Teng, “Human estrogen receptor-like 1 (ESRL1) gene: genomic organization, chromosomal localization, and promoter characterization,” Genomics, vol. 44, no. 1, pp. 52–60, 1997. View at Publisher · View at Google Scholar · View at Scopus
  31. P. T. K. Saunders, “Oestrogen receptor beta (ERβ),” Reviews of Reproduction, vol. 3, no. 3, pp. 164–171, 1998. View at Publisher · View at Google Scholar · View at Scopus
  32. J. F. Couse and K. S. Korach, “Estrogen receptor null mice: what have we learned and where will they lead us?” Endocrine Reviews, vol. 20, no. 3, pp. 358–417, 1999. View at Google Scholar · View at Scopus
  33. G. Delbès, C. Levacher, C. Duquenne, C. Racine, P. Pakarinen, and R. Habert, “Endogenous estrogens inhibit mouse fetal leydig cell development via estrogen receptor α,” Endocrinology, vol. 146, no. 5, pp. 2454–2461, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. M. E. Wilson, J. M. Westberry, and A. L. Trout, “Estrogen receptor-alpha gene expression in the cortex: sex differences during development and in adulthood,” Hormones and Behavior, vol. 59, no. 3, pp. 353–357, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. X. Fan, H. J. Kim, M. Warner, and J. A. Gustafsson, “Estrogen receptor β is essential for sprouting of nociceptive primary afferents and for morphogenesis and maintenance of the dorsal horn interneurons,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 34, pp. 13696–13701, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. D. D. Heidrich, S. Steckelbroeck, and D. Klingmuller, “Inhibition of human cytochrome P450 aromatase activity by butyltins,” Steroids, vol. 66, no. 10, pp. 763–769, 2001. View at Publisher · View at Google Scholar · View at Scopus
  37. M. H. A. Kester, S. Bulduk, D. Tibboel et al., “Potent inhibition of estrogen sulfotransferase by hydroxylated PCB metabolites: a novel pathway explaining the estrogenic activity of PCB's,” Endocrinology, vol. 141, no. 5, pp. 1897–1900, 2000. View at Publisher · View at Google Scholar · View at Scopus
  38. H. Déchaud, C. Ravard, F. Claustrat, A. B. de la Perrière, and M. Pugeat, “Xenoestrogen interaction with human sex hormone-binding globulin (hSHBG),” Steroids, vol. 64, no. 5, pp. 328–334, 1999. View at Publisher · View at Google Scholar · View at Scopus
  39. E. J. Routledge, R. White, M. G. Parker, and J. P. Sumpter, “Differential effects of xenoestrogens on coactivator recruitment by estrogen receptor (ER) α and ERβ,” The Journal of Biological Chemistry, vol. 275, no. 46, pp. 35986–35993, 2000. View at Publisher · View at Google Scholar · View at Scopus
  40. S. Jagadeesh, S. Kyo, and P. P. Banerjee, “Genistein represses telomerase activity via both transcriptional and posttranslational mechanisms in human prostate cancer cells,” Cancer Research, vol. 66, no. 4, pp. 2107–2115, 2006. View at Publisher · View at Google Scholar · View at Scopus
  41. P. H. Watson, R. T. Pon, and R. P. C. Shiu, “Inhibition of c-myc expression by phosphorothioate antisense oligonucleotide identifies a critical role for c-myc in the growth of human breast cancer,” Cancer Research, vol. 51, no. 15, pp. 3996–4000, 1991. View at Google Scholar · View at Scopus
  42. F. Martin, J. A. Reig, and B. Soria, “Secretagogue-induced [Ca2+]i changes in single rat pancreatic islets and correlation with simultaneously measured insulin release,” Journal of Molecular Endocrinology, vol. 15, no. 2, pp. 177–185, 1995. View at Google Scholar · View at Scopus
  43. X. Li, S. Zhang, and S. Safe, “Activation of kinase pathways in MCF-7 cells by 17β-estradiol and structurally diverse estrogenic compounds,” Journal of Steroid Biochemistry and Molecular Biology, vol. 98, no. 2-3, pp. 122–132, 2006. View at Publisher · View at Google Scholar · View at Scopus
  44. H. Cho and B. S. Katzenellenbogen, “Synergistic activation of estrogen receptor-mediated transcription by estradiol and protein kinase activators,” Molecular Endocrinology, vol. 7, no. 3, pp. 441–452, 1993. View at Publisher · View at Google Scholar · View at Scopus
  45. F. Ohtake, K. I. Takeyama, T. Matsumoto et al., “Modulation of oestrogen receptor signalling by association with the activated dioxin receptor,” Nature, vol. 423, no. 6939, pp. 545–550, 2003. View at Publisher · View at Google Scholar · View at Scopus
  46. S. Safe and M. Wormke, “Inhibitory aryl hydrocarbon receptor-estrogen receptor α cross-talk and mechanisms of action,” Chemical Research in Toxicology, vol. 16, no. 7, pp. 807–816, 2003. View at Google Scholar · View at Scopus
  47. S. Khan, R. Barhoumi, R. Burghardt, S. Liu, K. Kim, and S. Safe, “Molecular mechanism of inhibitory aryl hydrocarbon receptor—estrogen receptor/Sp1 cross talk in breast cancer cells,” Molecular Endocrinology, vol. 20, no. 9, pp. 2199–2214, 2006. View at Publisher · View at Google Scholar · View at Scopus
  48. J. Matthews, B. Wihlén, J. Thomsen, and J. A. Gustafsson, “Aryl hydrocarbon receptor-mediated transcription: ligand-dependent recruitment of estrogen receptor α to 2,3,7,8-tetrachlorodibenzo-p-dioxin- responsive promoters,” Molecular and Cellular Biology, vol. 25, no. 13, pp. 5317–5328, 2005. View at Publisher · View at Google Scholar · View at Scopus
  49. P. Pocar, B. Fischer, T. Klonisch, and S. Hombach-Klonisch, “Molecular interactions of the aryl hydrocarbon receptor and its biological and toxicological relevance for reproduction,” Reproduction, vol. 129, no. 4, pp. 379–389, 2005. View at Publisher · View at Google Scholar · View at Scopus
  50. M. Wormke, M. Stoner, B. Saville et al., “The aryl hydrocarbon receptor mediates degradation of estrogen receptor α through activation of proteasomes,” Molecular and Cellular Biology, vol. 23, no. 6, pp. 1843–1855, 2003. View at Publisher · View at Google Scholar · View at Scopus
  51. R. Le Guével, F. G. Petit, P. Le Goff, R. Métivier, Y. Valotaire, and F. Pakdel, “Inhibition of rainbow trout (Oncorhynchus mykiss) estrogen receptor activity by cadmium,” Biology of Reproduction, vol. 63, no. 1, pp. 259–266, 2000. View at Google Scholar · View at Scopus
  52. M. D. Johnson, N. Kenney, A. Stoica et al., “Cadmium mimics the in vivo effects of estrogen in the uterus and mammary gland,” Nature Medicine, vol. 9, no. 8, pp. 1081–1084, 2003. View at Publisher · View at Google Scholar · View at Scopus
  53. E. Silva, M. J. Lopez-Espinosa, J. M. Molina-Molina, M. Fernández, N. Olea, and A. Kortenkamp, “Lack of activity of cadmium in in vitro estrogenicity assays,” Toxicology and Applied Pharmacology, vol. 216, pp. 20–28, 2006. View at Google Scholar
  54. M. Takiguchi and S. Yoshihara, “New aspects of cadmium as endocrine disruptor,” Environmental Sciences, vol. 13, no. 2, pp. 107–116, 2006. View at Google Scholar · View at Scopus
  55. A. Stoica, B. S. Katzenellenbogen, and M. B. Martin, “Activation of estrogen receptor-α by the heavy metal cadmium,” Molecular Endocrinology, vol. 14, no. 4, pp. 545–553, 2000. View at Publisher · View at Google Scholar · View at Scopus
  56. C. Byrne, S. D. Divekar, G. B. Storchan, D. A. Parodi, and M. B. Martin, “Metals and breast cancer,” Journal of Mammary Gland Biology and Neoplasia, vol. 18, pp. 63–73, 2013. View at Google Scholar
  57. S. D. Divekar, G. B. Storchan, K. Sperle et al., “The role of calcium in the activation of estrogen receptor-alpha,” Cancer Research, vol. 71, no. 5, pp. 1658–1668, 2011. View at Publisher · View at Google Scholar · View at Scopus
  58. L. J. Guillette Jr., T. S. Gross, G. R. Masson, J. M. Matter, H. F. Percival, and A. R. Woodward, “Developmental abnormalities of the gonad and abnormal sex hormone concentrations in juvenile alligators from contaminated and control lakes in Florida,” Environmental Health Perspectives, vol. 102, no. 8, pp. 680–688, 1994. View at Google Scholar · View at Scopus
  59. W. R. Kelce, C. R. Stone, S. C. Laws, L. E. Gray, J. A. Kemppainen, and E. M. Wilson, “Persistent DDT metabolite p,p'-DDE is a potent androgen receptor antagonist,” Nature, vol. 375, no. 6532, pp. 581–585, 1995. View at Google Scholar · View at Scopus
  60. K. Yamasaki, H. Okuda, T. Takeuchi, and Y. Minobe, “Effects of in utero through lactational exposure to dicyclohexyl phthalate and p,p'-DDE in Sprague-Dawley rats,” Toxicology Letters, vol. 189, no. 1, pp. 14–20, 2009. View at Publisher · View at Google Scholar · View at Scopus
  61. A. Thiel, S. Guth, S. Böhm, and G. Eisenbrand, “Dicofol degradation to p,p'-dichlorobenzophenone—a potential antiandrogen,” Toxicology, vol. 282, no. 3, pp. 88–93, 2011. View at Publisher · View at Google Scholar · View at Scopus
  62. A. Adamsson, V. Salonen, J. Paranko, and J. Toppari, “Effects of maternal exposure to di-isononylphthalate (DINP) and 1,1-dichloro-2,2-bis(p-chlorophenyl)ethylene (p,p'-DDE) on steroidogenesis in the fetal rat testis and adrenal gland,” Reproductive Toxicology, vol. 28, no. 1, pp. 66–74, 2009. View at Publisher · View at Google Scholar · View at Scopus
  63. C. G. Campbell, S. E. Borglin, F. B. Green, A. Grayson, E. Wozei, and W. T. Stringfellow, “Biologically directed environmental monitoring, fate, and transport of estrogenic endocrine disrupting compounds in water: a review,” Chemosphere, vol. 65, no. 8, pp. 1265–1280, 2006. View at Publisher · View at Google Scholar · View at Scopus
  64. S. Rodriguez-Mozaz, M. J. L. de Alda, and D. Barceló, “Picogram per liter level determination of estrogens in natural waters and waterworks by a fully automated on-line solid-phase extraction-liquid chromatography-electrospray tandem mass spectrometry method,” Analytical Chemistry, vol. 76, no. 23, pp. 6998–7006, 2005. View at Publisher · View at Google Scholar · View at Scopus
  65. A. Peñalver, E. Pocurull, F. Borrull, and R. M. Marcé, “Method based on solid-phase microextraction-high-performance liquid chromatography with UV and electrochemical detection to determine estrogenic compounds in water samples,” Journal of Chromatography A, vol. 964, no. 1-2, pp. 153–160, 2002. View at Publisher · View at Google Scholar · View at Scopus
  66. J. Carpinteiro, J. B. Quintana, I. Rodríguez, A. M. Carro, R. A. Lorenzo, and R. Cela, “Applicability of solid-phase microextraction followed by on-fiber silylation for the determination of estrogens in water samples by gas chromatography-tandem mass spectrometry,” Journal of Chromatography A, vol. 1056, no. 1-2, pp. 179–185, 2004. View at Publisher · View at Google Scholar · View at Scopus
  67. F. Bianchi, M. Mattarozzi, M. Careri et al., “An SPME-GC-MS method using an octadecyl silica fibre for the determination of the potential angiogenesis modulators 17β-estradiol and 2-methoxyestradiol in culture media,” Analytical and Bioanalytical Chemistry, vol. 396, no. 7, pp. 2639–2645, 2010. View at Publisher · View at Google Scholar · View at Scopus
  68. J. M. F. Nogueira, “Novel sorption-based methodologies for static microextraction analysis: a review on SBSE and related techniques,” Analytica Chimica Acta, vol. 757, pp. 1–10, 2012. View at Google Scholar
  69. H. G. J. Mol, S. Sunarto, and O. M. Steijger, “Determination of endocrine disruptors in water after derivatization with N-methyl-N-(tert.-butyldimethyltrifluoroacetamide) using gas chromatography with mass spectrometric detection,” Journal of Chromatography A, vol. 879, no. 1, pp. 97–112, 2000. View at Publisher · View at Google Scholar · View at Scopus
  70. M. Farré, L. Kantiani, M. Petrovic, S. Pérez, and D. Barceló, “Achievements and future trends in the analysis of emerging organic contaminants in environmental samples by mass spectrometry and bioanalytical techniques,” Journal of Chromatography A, vol. 1259, pp. 86–99, 2012. View at Google Scholar
  71. S. Biau, S. Bayle, P. D. Barbara, and B. Roig, “The chick embryo: an animal model for detection of the effects of hormonal compounds,” Analytical and Bioanalytical Chemistry, vol. 387, no. 4, pp. 1397–1403, 2007. View at Publisher · View at Google Scholar · View at Scopus
  72. W. D. Isenhower Jr., R. R. Newbold, R. C. Cefalo, K. S. Korach, and J. A. McLachlan, “Absence of estrogenic activity in some drugs commonly used during pregnancy,” Biological Research in Pregnancy and Perinatology, vol. 7, no. 1, pp. 6–10, 1986. View at Google Scholar · View at Scopus
  73. E. Padilla-Banks, W. N. Jefferson, and R. R. Newbold, “The immature mouse is a suitable model for detection of estrogenicity in the uterotropic bioassay,” Environmental Health Perspectives, vol. 109, no. 8, pp. 821–826, 2001. View at Google Scholar · View at Scopus
  74. J. Kanno, L. Onyon, J. Haseman, P. Fenner-Crisp, J. Ashby, and W. Owens, “The OECD program to validate the rat uterotrophic bioassay to screen compounds for in vivo estrogenic responses: phase 1,” Environmental Health Perspectives, vol. 109, no. 8, pp. 785–794, 2001. View at Google Scholar · View at Scopus
  75. G. Flouriot, F. Pakdel, B. Ducouret, and Y. Valotaire, “Influence of xenobiotics on rainbow trout liver estrogen receptor and vitellogenin gene expression,” Journal of Molecular Endocrinology, vol. 15, no. 2, pp. 143–151, 1995. View at Google Scholar · View at Scopus
  76. C. R. Tyler, J. P. Sumpter, and P. R. Witthames, “The dynamics of oocyte growth during vitellogenesis in the rainbow trout (Oncorhynchus mykiss),” Biology of Reproduction, vol. 43, no. 2, pp. 202–209, 1990. View at Publisher · View at Google Scholar · View at Scopus
  77. F. R. Knudsen, A. E. Schou, M. L. Wiborg et al., “Increase of plasma vitellogenin concentration in rainbow trout (Oncorhynchus mykiss) exposed to effluents from oil refinery treatment works and municipal sewage,” Bulletin of Environmental Contamination and Toxicology, vol. 59, no. 5, pp. 802–806, 1997. View at Publisher · View at Google Scholar · View at Scopus
  78. F. Brion, Y. Le Page, B. Piccini et al., “Screening estrogenic activities of chemicals or mixtures in vivo using transgenic (cyp19a1b-GFP) zebrafish embryos,” PLoS ONE, vol. 7, no. 5, Article ID e36069, 2012. View at Google Scholar
  79. P. Ciana, G. Di Luccio, S. Belcredito et al., “Engineering of a mouse for the in vivo profiling of estrogen receptor activity,” Molecular Endocrinology, vol. 15, no. 7, pp. 1104–1113, 2001. View at Publisher · View at Google Scholar · View at Scopus
  80. O. Lee, A. Takesono, M. Tada, C. R. Tyler, and T. Kudoh, “Biosensor zebrafish provide new insights into potential health effects of environmental estrogens,” Environmental Health Perspectives, vol. 120, pp. 990–996, 2012. View at Google Scholar
  81. H. Chen, J. Hu, J. Yang et al., “Generation of a fluorescent transgenic zebrafish for detection of environmental estrogens,” Aquatic Toxicology, vol. 96, no. 1, pp. 53–61, 2010. View at Publisher · View at Google Scholar · View at Scopus
  82. A. M. Soto, C. Sonnenschein, K. L. Chung, M. F. Fernandez, N. Olea, and F. O. Serrano, “The E-SCREEN assay as a tool to identify estrogens: an update on estrogenic environmental pollutants,” Environmental Health Perspectives, vol. 103, supplement 7, pp. 113–122, 1995. View at Google Scholar · View at Scopus
  83. P. Balaguer, F. François, F. Comunale et al., “Reporter cell lines to study the estrogenic effects of xenoestrogens,” Science of the Total Environment, vol. 233, no. 1–3, pp. 47–56, 1999. View at Publisher · View at Google Scholar · View at Scopus
  84. D. Habauzit, A. Boudot, G. Kerdivel, G. Flouriot, and F. Pakdel, “Development and validation of a test for environmental estrogens: checking xeno-estrogen activity by CXCL12 secretion in Breast Cancer Cell Lines (CXCL-test),” Environmental Toxicology, vol. 25, no. 5, pp. 495–503, 2010. View at Publisher · View at Google Scholar · View at Scopus
  85. J. C. Swart, E. J. Pool, and J. H. van Wyk, “The implementation of a battery of in vivo and in vitro bioassays to assess river water for estrogenic endocrine disrupting chemicals,” Ecotoxicology and Environmental Safety, vol. 74, no. 1, pp. 138–143, 2011. View at Publisher · View at Google Scholar · View at Scopus
  86. J. Legler, C. E. van den Brink, A. Brouwer et al., “Development of a stably transfected estrogen receptor-mediated luciferase reporter gene assay in the human T47D breast cancer cell line,” Toxicological Sciences, vol. 48, no. 1, pp. 55–66, 1999. View at Publisher · View at Google Scholar · View at Scopus
  87. S. F. Arnold, M. K. Robinson, A. C. Notides, L. J. Guillette, and J. A. McLachan, “A yeast estrogen screen for examining the relative exposure of cells to natural and xenoestrogens,” Environmental Health Perspectives, vol. 104, no. 5, pp. 544–548, 1996. View at Google Scholar · View at Scopus
  88. F. Petit, P. Le Goff, J. P. Cravédi, Y. Valotaire, and F. Pakdel, “Two complementary bioassays for screening the estrogenic potency of xenobiotics: recombinant yeast for trout estrogen receptor and trout hepatocyte cultures,” Journal of Molecular Endocrinology, vol. 19, no. 3, pp. 321–335, 1997. View at Publisher · View at Google Scholar · View at Scopus
  89. F. Petit, Y. Valotaire, and F. Pakdel, “Differential functional activities of rainbow trout and human estrogen receptors expressed in the yeast Saccharomyces cerevisiae,” European Journal of Biochemistry, vol. 233, no. 2, pp. 584–592, 1995. View at Google Scholar · View at Scopus
  90. Y. Le Page, M. Scholze, O. Kah, and F. Pakdel, “Assessment of xenoestrogens using three distinct estrogen receptors and the zebrafish brain aromatase gene in a highly responsive glial cell system,” Environmental Health Perspectives, vol. 114, no. 5, pp. 752–758, 2006. View at Publisher · View at Google Scholar · View at Scopus
  91. H. R. Andersen, A. M. Andersson, S. F. Arnold et al., “Comparison of short-term estrogenicity tests for identification of hormone-disrupting chemicals,” Environmental Health Perspectives, vol. 107, supplement 1, pp. 89–108, 1999. View at Google Scholar · View at Scopus
  92. N. Fujimoto, H. Honda, and S. Kitamura, “Effects of environmental estrogenic chemicals on AP1 mediated transcription with estrogen receptors α and β,” Journal of Steroid Biochemistry and Molecular Biology, vol. 88, no. 1, pp. 53–59, 2004. View at Publisher · View at Google Scholar · View at Scopus
  93. D. Habauzit, G. Flouriot, F. Pakdel, and C. Saligaut, “Effects of estrogens and endocrine-disrupting chemicals on cell differentiation-survival-proliferation in brain: contributions of neuronal cell lines,” Journal of Toxicology and Environmental Health B, vol. 14, no. 5–7, pp. 300–327, 2011. View at Publisher · View at Google Scholar · View at Scopus
  94. M. D. Shelby, R. R. Newbold, D. B. Tully, K. Chae, and V. L. Davis, “Assessing environmental chemicals for estrogenicity using a combination of in vitro and in vivo assays,” Environmental Health Perspectives, vol. 104, no. 12, pp. 1296–1300, 1996. View at Google Scholar · View at Scopus
  95. L. C. Clark Jr. and C. Lyons, “Electrode systems for continuous monitoring in cardiovascular surgery,” Annals of the New York Academy of Sciences, vol. 102, pp. 29–45, 1962. View at Google Scholar · View at Scopus
  96. S. Rodriguez-Mozaz, M. P. Marco, M. J. L. de Alda, and D. Barceló, “Biosensors for environmental monitoring of endocrine disruptors: a review article,” Analytical and Bioanalytical Chemistry, vol. 378, no. 3, pp. 588–598, 2004. View at Publisher · View at Google Scholar · View at Scopus
  97. P. D'Ursi, E. Salvi, P. Fossa, L. Milanesi, and E. Rovida, “Modelling the interaction of steroid receptors with endocrine disrupting chemicals,” BMC Bioinformatics, vol. 6, supplement 4, article S10, 2005. View at Publisher · View at Google Scholar · View at Scopus
  98. H. Kanso, L. Barthelmebs, N. Inguimbert, and T. Noguer, “Immunosensors for estradiol and ethinylestradiol based on new synthetic estrogen derivatives: application to wastewater analysis,” Analytical Chemistry, vol. 85, pp. 2397–2404, 2013. View at Google Scholar
  99. M. Usami, K. Mitsunaga, and Y. Ohno, “Estrogen receptor binding assay of chemicals with a surface plasmon resonance biosensor,” Journal of Steroid Biochemistry and Molecular Biology, vol. 81, no. 1, pp. 47–55, 2002. View at Publisher · View at Google Scholar · View at Scopus
  100. M. Seifert, S. Haindl, and B. Hock, “Development of an enzyme linked receptor assay (ELRA) for estrogens and xenoestrogens,” Analytica Chimica Acta, vol. 386, no. 3, pp. 191–199, 1999. View at Publisher · View at Google Scholar · View at Scopus
  101. R. L. Rich, L. R. Hoth, K. F. Geoghegan et al., “Kinetic analysis of estrogen receptor/ligand interactions,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 13, pp. 8562–8567, 2002. View at Publisher · View at Google Scholar · View at Scopus
  102. P. Fechner, F. Pröll, M. Carlquist, and G. Proll, “An advanced biosensor for the prediction of estrogenic effects of endocrine-disrupting chemicals on the estrogen receptor alpha,” Analytical and Bioanalytical Chemistry, vol. 393, no. 6-7, pp. 1579–1585, 2009. View at Publisher · View at Google Scholar · View at Scopus
  103. R. Paulmurugan and S. S. Gambhir, “An intramolecular folding sensor for imaging estrogen receptor-ligand interactions,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 43, pp. 15883–15888, 2006. View at Publisher · View at Google Scholar · View at Scopus
  104. S. B. Kim, M. Sato, and H. Tao, “Molecular tension-indexed bioluminescent probe for determining protein-protein interactions,” Bioconjugate Chemistry, vol. 20, no. 12, pp. 2324–2330, 2009. View at Publisher · View at Google Scholar · View at Scopus
  105. B. K. Sung, Y. Umezawa, K. A. Kanno, and H. Tao, “An integrated-molecule-format multicolor probe for monitoring multiple activities of a bioactive small molecule,” ACS Chemical Biology, vol. 3, no. 6, pp. 359–372, 2008. View at Publisher · View at Google Scholar · View at Scopus
  106. E. Jisa, E. Dornstauder, S. Ogawa, S. Inoue, M. Muramatsu, and A. Jungbauer, “Transcriptional activities of estrogen receptor alpha and beta in yeast properties of raloxifene,” Biochemical Pharmacology, vol. 62, no. 7, pp. 953–961, 2001. View at Publisher · View at Google Scholar · View at Scopus
  107. A. Berthier, C. Elie-Caille, E. Lesniewska, R. Delage-Mourroux, and W. Boireau, “Label-free sensing and atomic force spectroscopy for the characterization of protein-DNA and protein-protein interactions: application to estrogen receptors,” Journal of Molecular Recognition, vol. 24, no. 3, pp. 429–435, 2011. View at Publisher · View at Google Scholar · View at Scopus
  108. B. J. Cheskis, S. Karathanasis, and C. R. Lyttle, “Estrogen receptor ligands modulate its interaction with DNA,” The Journal of Biological Chemistry, vol. 272, no. 17, pp. 11384–11391, 1997. View at Publisher · View at Google Scholar · View at Scopus
  109. D. Habauzit, J. Armengaud, B. Roig, and J. Chopineau, “Determination of estrogen presence in water by SPR using estrogen receptor dimerization,” Analytical and Bioanalytical Chemistry, vol. 390, no. 3, pp. 873–883, 2008. View at Publisher · View at Google Scholar · View at Scopus
  110. D. Habauzit, J. Chopineau, and B. Roig, “SPR-based biosensors: a tool for biodetection of hormonal compounds,” Analytical and Bioanalytical Chemistry, vol. 387, no. 4, pp. 1215–1223, 2007. View at Publisher · View at Google Scholar · View at Scopus
  111. W. Y. X. Peh, E. Reimhult, F. T. Huey, J. S. Thomsen, and X. Su, “Understanding ligand binding effects on the conformation of estrogen receptor α-DNA complexes: a combinational quartz crystal microbalance with dissipation and surface plasmon resonance study,” Biophysical Journal, vol. 92, no. 12, pp. 4415–4423, 2007. View at Publisher · View at Google Scholar · View at Scopus
  112. A. Bouter, N. Buisine, A. Le Grand et al., “Control of vitellogenin genes expression by sequences derived from transposable elements in rainbow trout,” Biochimica et Biophysica Acta, vol. 1799, no. 8, pp. 546–554, 2010. View at Publisher · View at Google Scholar · View at Scopus
  113. M. Szatkowski Ozers, J. J. Hill, K. Ervin, C. A. Royer, and J. Gorski, “The dissociation rate of estrogen receptor α from the consensus estrogen response element,” Molecular and Cellular Endocrinology, vol. 175, no. 1-2, pp. 101–109, 2001. View at Publisher · View at Google Scholar · View at Scopus
  114. M. S. Ozers, J. J. Hill, K. Ervin et al., “Equilibrium binding of estrogen receptor with DNA using fluorescence anisotropy,” The Journal of Biological Chemistry, vol. 272, no. 48, pp. 30405–30411, 1997. View at Publisher · View at Google Scholar · View at Scopus
  115. A. Tamrazi, K. E. Carlson, J. R. Daniels, K. M. Hurth, and J. A. Katzenellenbogen, “Estrogen receptor dimerization: ligand binding regulates dimer affinity and dimer dissociation rate,” Molecular Endocrinology, vol. 16, no. 12, pp. 2706–2719, 2002. View at Publisher · View at Google Scholar · View at Scopus
  116. E. Swedenborg and I. Pongratz, “AhR and ARNT modulate ER signaling,” Toxicology, vol. 268, no. 3, pp. 132–138, 2010. View at Publisher · View at Google Scholar · View at Scopus
  117. R. R. Newbold, R. B. Hanson, W. N. Jefferson, B. C. Bullock, J. Haseman, and J. A. McLachlan, “Increased tumors but uncompromised fertility in the female descendants of mice exposed developmentally to diethylstilbestrol,” Carcinogenesis, vol. 19, no. 9, pp. 1655–1663, 1998. View at Publisher · View at Google Scholar · View at Scopus
  118. R. L. Jirtle and M. K. Skinner, “Environmental epigenomics and disease susceptibility,” Nature Reviews Genetics, vol. 8, no. 4, pp. 253–262, 2007. View at Publisher · View at Google Scholar · View at Scopus
  119. M. D. Anway, A. S. Cupp, N. Uzumcu, and M. K. Skinner, “Toxicology: epigenetic transgenerational actions of endocrine disruptors and male fertility,” Science, vol. 308, no. 5727, pp. 1466–1469, 2005. View at Publisher · View at Google Scholar · View at Scopus
  120. M. D. Anway, C. Leathers, and M. K. Skinner, “Endocrine disruptor vinclozolin induced epigenetic transgenerational adult-onset disease,” Endocrinology, vol. 147, no. 12, pp. 5515–5523, 2006. View at Publisher · View at Google Scholar · View at Scopus
  121. H. S. Chang, M. D. Anway, S. S. Rekow, and M. K. Skinner, “Transgenerational epigenetic imprinting of the male germline by endocrine disruptor exposure during gonadal sex determination,” Endocrinology, vol. 147, pp. 5524–5541, 2006. View at Google Scholar
  122. R. Kavlock and A. Cummings, “Mode of action: inhibition of androgen receptor function—vinclozolin-induced malformations in reproductive development,” Critical Reviews in Toxicology, vol. 35, no. 8-9, pp. 721–726, 2005. View at Publisher · View at Google Scholar · View at Scopus
  123. M. Manikkam, C. Guerrero-Bosagna, R. Tracey, M. M. Haque, and M. K. Skinner, “Transgenerational actions of environmental compounds on reproductive disease and identification of epigenetic biomarkers of ancestral exposures,” PLoS ONE, vol. 7, Article ID e31901, 2012. View at Google Scholar
  124. J. M. Molina-Molina, A. Hillenweck, I. Jouanin et al., “Steroid receptor profiling of vinclozolin and its primary metabolites,” Toxicology and Applied Pharmacology, vol. 216, pp. 44–54, 2006. View at Google Scholar
  125. E. Nilsson, G. Larsen, M. Manikkam, C. Guerrero-Bosagna, M. I. Savenkova, and M. K. Skinner, “Environmentally induced epigenetic transgenerational inheritance of ovarian disease,” PLoS ONE, vol. 7, no. 10, Article ID e36129, 2012. View at Google Scholar
  126. C. M. Revankar, D. F. Cimino, L. A. Sklar, J. B. Arterburn, and E. R. Prossnitz, “A transmembrane intracellular estrogen receptor mediates rapid cell signaling,” Science, vol. 307, no. 5715, pp. 1625–1630, 2005. View at Publisher · View at Google Scholar · View at Scopus
  127. E. J. Filardo, J. A. Quinn, A. R. Frackelton, and K. I. Bland, “Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis,” Molecular Endocrinology, vol. 16, no. 1, pp. 70–84, 2002. View at Publisher · View at Google Scholar · View at Scopus
  128. M. Maggiolini, A. Vivacqua, G. Fasanella et al., “The G protein-coupled receptor GPR30 mediates c-fos up-regulation by 17β-estradiol and phytoestrogens in breast cancer cells,” The Journal of Biological Chemistry, vol. 279, no. 26, pp. 27008–27016, 2004. View at Publisher · View at Google Scholar · View at Scopus
  129. A. Vivacqua, D. Bonofiglio, L. Albanito et al., “17β-estradiol, genistein, and 4-hydroxytamoxifen induce the proliferation of thyroid cancer cells through the G protein-coupled receptor GPR30,” Molecular Pharmacology, vol. 70, no. 4, pp. 1414–1423, 2006. View at Publisher · View at Google Scholar · View at Scopus
  130. P. Thomas and J. Dong, “Binding and activation of the seven-transmembrane estrogen receptor GPR30 by environmental estrogens: a potential novel mechanism of endocrine disruption,” Journal of Steroid Biochemistry and Molecular Biology, vol. 102, no. 1–5, pp. 175–179, 2006. View at Publisher · View at Google Scholar · View at Scopus
  131. C. S. Watson, R. A. Alyea, Y. J. Jeng, and M. Y. Kochukov, “Nongenomic actions of low concentration estrogens and xenoestrogens on multiple tissues,” Molecular and Cellular Endocrinology, vol. 274, no. 1-2, pp. 1–7, 2007. View at Publisher · View at Google Scholar · View at Scopus
  132. J. Tiefenbach, P. R. Moll, M. R. Nelson et al., “A live zebrafish-based screening system for human nuclear receptor ligand and cofactor discovery,” PloS ONE, vol. 5, no. 3, Article ID e9797, 2010. View at Google Scholar · View at Scopus